BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 18463167)

  • 21. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
    Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
    Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of the platelet-derived growth factor receptor-beta and epidermal growth factor receptor by G protein-coupled receptor kinase-2. Mechanisms for selectivity of desensitization.
    Freedman NJ; Kim LK; Murray JP; Exum ST; Brian L; Wu JH; Peppel K
    J Biol Chem; 2002 Dec; 277(50):48261-9. PubMed ID: 12381737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition.
    Wu JH; Goswami R; Kim LK; Miller WE; Peppel K; Freedman NJ
    J Biol Chem; 2005 Sep; 280(35):31027-35. PubMed ID: 15994317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase.
    Sarnago S; Elorza A; Mayor F
    J Biol Chem; 1999 Nov; 274(48):34411-6. PubMed ID: 10567420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.
    Eisinger DA; Ammer H
    J Biol Chem; 2009 Dec; 284(50):34819-28. PubMed ID: 19828455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
    Shao H; Wu C; Wells A
    J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.
    Graness A; Hanke S; Boehmer FD; Presek P; Liebmann C
    Biochem J; 2000 Apr; 347(Pt 2):441-7. PubMed ID: 10749673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAPK-dependent degradation of G protein-coupled receptor kinase 2.
    Elorza A; Penela P; Sarnago S; Mayor F
    J Biol Chem; 2003 Aug; 278(31):29164-73. PubMed ID: 12738776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HGF-independent potentiation of EGFR action by c-Met.
    Dulak AM; Gubish CT; Stabile LP; Henry C; Siegfried JM
    Oncogene; 2011 Aug; 30(33):3625-35. PubMed ID: 21423210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of tyrosine kinase of EGFR induces Gbetagamma-dependent GRK-EGFR complex formation.
    Gao J; Li J; Chen Y; Ma L
    FEBS Lett; 2005 Jan; 579(1):122-6. PubMed ID: 15620700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Fc∈RI signaling in mast cells by G protein-coupled receptor kinase 2 and its RH domain.
    Subramanian H; Gupta K; Parameswaran N; Ali H
    J Biol Chem; 2014 Jul; 289(30):20917-27. PubMed ID: 24904059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation.
    Shi CS; Kehrl JH
    J Biol Chem; 2004 Apr; 279(17):17224-31. PubMed ID: 14963038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor.
    Nanjundan M; Sun J; Zhao J; Zhou Q; Sims PJ; Wiedmer T
    J Biol Chem; 2003 Sep; 278(39):37413-8. PubMed ID: 12871937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists.
    Marie N; Aguila B; Hasbi A; Davis A; Jauzac P; Allouche S
    Cell Signal; 2008 Jun; 20(6):1209-20. PubMed ID: 18395423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling.
    Rodrigues GA; Falasca M; Zhang Z; Ong SH; Schlessinger J
    Mol Cell Biol; 2000 Feb; 20(4):1448-59. PubMed ID: 10648629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition.
    Salazar G; González A
    Mol Biol Cell; 2002 May; 13(5):1677-93. PubMed ID: 12006662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.
    Olayioye MA; Beuvink I; Horsch K; Daly JM; Hynes NE
    J Biol Chem; 1999 Jun; 274(24):17209-18. PubMed ID: 10358079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.